STOCK TITAN

Madison Avenue group reports 6.6% Veradigm (MDRX) stake in Schedule 13G

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Veradigm Inc. (MDRX) has a new significant shareholder group led by Madison Avenue International LP. As of January 29, 2026, the group reports beneficial ownership of 7,167,999 shares of common stock, equal to about 6.6% of Veradigm’s outstanding shares.

The ownership percentage is calculated using 108,900,000 shares outstanding as of September 29, 2025, as cited from a prior company press release. The filing is made jointly by several related investment entities and Eli Samaha, who may be deemed to share voting and dispositive power. They certify the holdings are not for the purpose of changing or influencing control of Veradigm, other than activities solely in connection with a director nomination process.

Positive

  • None.

Negative

  • None.

Insights

A new 6.6% holder discloses a sizable but passive stake.

The reporting group, led by Madison Avenue International LP, reports beneficial ownership of 7,167,999 Veradigm common shares, or about 6.6% as of January 29, 2026. This makes them a notable institutional holder above the 5% disclosure threshold.

Control of the position is layered through several entities, with Eli Samaha potentially deemed a beneficial owner via management roles in Madison Avenue GP, EMAI Management, and Caraway Jackson Investments. The structure centralizes influence over voting and disposition decisions within this investment complex.

The group certifies that the shares were not acquired to change or influence control, referencing only potential activities tied to a nomination under Rule 14a-11. Actual future impact depends on how actively they vote their 6.6% stake and on any subsequent ownership or governance disclosures.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Madison Avenue International LP
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner
Date:01/29/2026
Madison Avenue Partners, LP
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner
Date:01/29/2026
EMAI Management, LLC
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Managing Member
Date:01/29/2026
Madison Avenue GP, LLC
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Manager
Date:01/29/2026
Caraway Jackson Investments LLC
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Member
Date:01/29/2026
Eli Samaha
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha
Date:01/29/2026
Exhibit Information

Exhibit A - Joint Filing Agreement

FAQ

How much of Veradigm Inc. (MDRX) stock does Madison Avenue International LP beneficially own?

Madison Avenue International LP and related entities report beneficial ownership of 7,167,999 shares of Veradigm common stock, representing about 6.6% of the company’s outstanding shares, based on 108,900,000 shares outstanding as of September 29, 2025.

Who are the reporting persons in the Veradigm (MDRX) Schedule 13G?

The reporting persons are Madison Avenue International LP, Madison Avenue Partners, LP, EMAI Management, LLC, Madison Avenue GP, LLC, Caraway Jackson Investments LLC, and Eli Samaha, which together form a group reporting a single combined beneficial ownership position.

What percentage of Veradigm (MDRX) does the Madison Avenue group own and how was it calculated?

The group may be deemed to own approximately 6.6% of Veradigm’s common stock. This percentage is based on 108,900,000 shares outstanding as of September 29, 2025, a figure taken from a Veradigm press release referenced in the disclosure.

Does the Madison Avenue group intend to influence control of Veradigm Inc. (MDRX)?

The reporting persons certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Veradigm, other than activities solely in connection with a nomination under Rule 14a-11, indicating a primarily passive investment stance.

What voting and dispositive power does the Madison Avenue group report over Veradigm (MDRX) shares?

Each reporting person lists 0 shares with sole voting or dispositive power and 7,167,999 shares with shared voting and shared dispositive power. This means decisions over these shares are coordinated among the group’s related entities and individuals.

What role does Eli Samaha play in the Veradigm (MDRX) shareholding group?

Eli Samaha may be deemed a beneficial owner through his roles as non-member manager of Madison Avenue GP, managing member of EMAI Management, and majority owner of Caraway Jackson Investments, giving him influence over the 7,167,999 Veradigm shares held by Madison Avenue International LP.
Veradigm

OTC:MDRX

MDRX Rankings

MDRX Latest News

MDRX Latest SEC Filings

MDRX Stock Data

499.56M
103.82M
4.28%
41.94%
Health Information Services
Healthcare
Link
United States
Chicago